To determine whether these results are due to IFN administration prior to infection, a result of an attenuated infection or a combination of both, we repeated the experiment comparing mice that received IFN-α with a group on neonatal mice that received palivizumab prior to RSV infection. Here, IFNA1 is linked to infection.